sm-346 and Infertility--Male

sm-346 has been researched along with Infertility--Male* in 1 studies

Other Studies

1 other study(ies) available for sm-346 and Infertility--Male

ArticleYear
Antimutagenic Effect of Afobazole on Blood Leukocytes in Individuals with Reproductive Dysfunction under Conditions of Anthropogenic Load.
    Bulletin of experimental biology and medicine, 2016, Volume: 162, Issue:2

    Increased frequency of cells with chromosomal aberrations was revealed in 48-h cultures of peripheral blood lymphocytes isolated North Ossetia residents with impaired reproductive function. After 2-week treatment with antimutagenic drug Afobazole, the percentage of cells with chromosomal aberrations significantly decreased from 3.77±0.20 to 2.48±0.24% (p<0.001). Significant differences between chromosome damage levels before and after administration of the drug suggest that Afobazole could be recommended for protective purposes to this group of patients.

    Topics: Adult; Antimutagenic Agents; Benzimidazoles; Case-Control Studies; Chromosome Aberrations; Cytogenetic Analysis; Drug Administration Schedule; Environmental Exposure; Female; Humans; Infertility, Female; Infertility, Male; Leukocytes, Mononuclear; Male; Metaphase; Morpholines; Mutagenesis; Treatment Outcome

2016